Stratus® Medical completes private placement financing and acquisition of the NimbusRF business for expansion in the interventional pain medicine space

SALT LAKE CITY, Jan. 15, 2020 /PRNewswire/ — Stratus™ Medical is a new company created to focus on advancing radiofrequency (RF) ablation treatment for chronic pain.  Today, Stratus Medical announced that it completed a private placement to acquire the assets of NimbusRF from Biomerics and provide growth capital funding to support the continued global expansion of the Nimbus® RF Multitined Expandable Electrode for chronic pain. The investment was led by Med Venture Holdings.

Nimbus was developed to address the unmet need for an easy to use, efficient, cost-effective RF device that provides a large volume and optimally shaped lesion, which interventional pain specialists, orthopedic surgeons and neurosurgeons can use to treat pain. Nimbus has been shown to reduce procedural time and increase efficiency for hospitals and surgery centers where Nimbus is utilized.  The Nimbus device is FDA cleared and CE marked.  Nimbus has been utilized in over 100,000 patient treatments in Australia, Brazil, Canada, United Kingdom, United States and other countries.

Bret Boudousquie, Stratus Medical CEO offered, “The rapidly growing global radiofrequency (RF) ablation for chronic pain market has been asking for innovation and Nimbus is well positioned to become the market leader in this space to treat chronic pain.  Nimbus offers a highly differentiated and patented technology to meet the needs of patients and physicians alike.  With the financial support and expertise from our lead investor, Med Venture Holdings, we will accelerate the global sales and marketing efforts of Nimbus and fund development of our new product pipeline.”

Travis Sessions, Med Venture Holdings Managing Partner commented, “We see great value in the interventional pain medicine space as so much emphasis is being placed on reducing the use of narcotics and improving interventional therapies to address chronic pain and improve quality of life.  We have been involved with the Nimbus product line for some time and have seen an excellent response from physician users, hospitals and ASC customers.  Under Bret’s proven leadership, we expect Nimbus to increase its global presence and Stratus Medical to bring innovation to the interventional pain space.”

About Stratus Medical – Stratus Medical is an early commercial stage medical device company focused on reducing pain and suffering and improving the quality of life for chronic pain patients through innovation.  Stratus Medical is headquartered in Salt Lake City, UT where their leading product, Nimbus, is manufactured. Learn more at stratusmedical.com

About Med Venture Holdings – Med Venture Holdings evaluates, develops, and invests in medical device technologies, products, and services to improve human health and wellness.  We partner with entrepreneurs, doctors, engineers, and business owners to provide the financing, relationships, and expertise to build value-creating businesses. Our combination of industry knowledge, regulatory compliance, operations, and finance make us a preferred partner.  Learn more at medventureholdings.com

Media Contact
Cody Jorgensen
Marketing Communications
Stratus Medical
801-355-2705
cody@stratusmedical.com
https://stratusmedical.com 

Investor Contact
Andy Montero
CFO
Stratus Medical
801-355-2705
andy@stratusmedical.com

Background:

Radiofrequency neurotomy (RFN) can be an effective treatment for patients with chronic neck pain and cervicogenic headaches resistant to conservative care. However, the degree and duration of pain relief after RFN is dependent upon the thoroughness of target nerve coagulation.

Case Report:

This is a case of a 37-year-old patient with debilitating neck pain and headaches following a motor vehicle accident. Successful local anesthetic block of the third occipital nerve (TON) confirmed pain of C2-C3 facet joint origin. An initial RFN treatment of the TON, using standard 18G electrodes in bipolar mode, resulted in complete symptom amelioration for 8 months. Repeat RFN, using the same electrode configuration, was unsuccessful in alleviating the severe neck pain and headaches, and produced no demonstrable sensory loss in the distribution of the TON. RFN was then performed using the NIMBUS® electrosurgical RF multitined expandable electrode, which provides a larger zone of coagulation in volume than standard RFN electrodes even when used in bipolar configuration.

Conclusion:

The NIMBUS procedure resulted in successful coagulation of the TON with sensory loss in the TON distribution and reinstatement of palliative relief.

.elementor-element-6a4dca25 .elementor-heading-title { color: #2A90C3 !important; font-weight: 400 !important; text-align: center !important; font-size: 31px !important; } .elementor-element-7f491b95 { text-align: center !important; } .elementor-element-7f491b95 .elementor-icon-list-text, .elementor-element-7f491b95 time { color: #54595F !important; } .elementor-element-7f491b95 a { color: #54595F !important; } .elementor-element-35001cdd > .e-con-inner { padding-left: 8% !important; padding-right: 8% !important; }